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Abstract
Background—Higher levels of sodium and lower levels of potassium intake are associated with 
higher blood pressure. However, the shape and magnitude of these associations can vary by study 
participant characteristics or intake assessment method. Twenty-four hour urinary excretion of 
sodium and potassium are unaffected by recall errors and represent all sources of intake, and were 
collected for the first time in a nationally representative US survey. Our objective was to assess the 
associations of blood pressure and hypertension with 24-hour urinary excretion of sodium and 
potassium among US adults.
Methods—Cross-sectional data from 766 participants aged 20–69 years with complete blood 
pressure and 24-hour urine collections in the 2014 National Health and Nutrition Examination 
Survey, a nationally-representative survey of the US noninstitutionalized population. Usual 24-
hour urinary electrolyte excretion (sodium, potassium, and their ratio) was estimated from up to 
two collections on non-consecutive days, adjusting for day-to-day variability in excretion. 
Outcomes included systolic and diastolic blood pressure from the average of 3 measures and 
hypertension status, based on average blood pressure ≥140/90 and anti-hypertensive medication 
use.
Results—After multivariable adjustment, each 1000 mg difference in usual 24-hour sodium 
excretion was directly associated with systolic (4.58 mmHg, 95% confidence interval 2.64,6.51) 
and diastolic (2.25 mmHg, 95% CI 0.83,3.67) blood pressures. Each 1000 mg difference in 
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potassium excretion was inversely associated with systolic blood pressure (−3.72 mmHg, 95% CI 
−6.01, −1.42). Each 0.5 unit difference in sodium-to-potassium ratio was directly associated with 
systolic blood pressure (1.72 mmHg, 95% CI 0.76, 2.68). Hypertension was linearly associated 
with progressively higher sodium and lower potassium excretion; compared with the lowest 
quartiles of excretion, the adjusted odds of hypertension for the highest quartiles were 4.22 (95% 
CI 1.36, 13.15) for sodium, and 0.38 (95% CI 0.17, 0.87) for potassium, respectively, P<0.01 for 
trends.
Conclusions—These cross-sectional results show a strong dose-response association between 
urinary sodium excretion and blood pressure, and an inverse association between urinary 
potassium excretion and blood pressure, in a nationally representative sample of US adults.
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INTRODUCTION
Hypertension is a key modifiable risk factor for cardiovascular disease (CVD), the leading 
cause of morbidity and mortality in the United States.1 Studies indicate that excess dietary 
sodium is related to increased blood pressure,2–4 while high potassium intake is related to 
lower blood pressure,5 and the sodium-to-potassium ratio may be more strongly associated 
with blood pressure than either sodium or potassium alone.6 However, most studies 
examining these associations have used self-reported dietary measures to estimate intake, 
including the National Health and Nutrition Examination Survey (NHANES), which has 
traditionally used 24-hour dietary recalls. Self-reported dietary intake is limited by 
participant ability to recall detailed information on foods and beverages, and portion sizes. 
In addition, food composition databases may not accurately reflect product reformulations, 
and dietary recalls do not capture sodium intake from salt added at the table.7 Dietary recalls 
may also be subject to differential bias across weight status categories, with more frequent 
under-reporting of intake among obese persons.8
Twenty-four hour urinary electrolyte excretion is not subject to the limitations of dietary 
measures. When collection is complete, 24-hour urine is recommended as the gold standard 
for assessing sodium intake.9, 10 Twenty-four hour dietary recalls may underestimate 
average sodium intake by 4%–34% compared to 24-hour urinary excretion.11, 12 Potassium 
intake estimated from dietary recalls may be higher than urinary excretion measures by up to 
16%.11, 12 Accounting for day-to-day variation in urinary excretion of electrolytes is 
required for assessment of intake in observational studies of health outcomes.11, 13
In 2014, for the first time, NHANES collected 24-hour urine samples and measured urinary 
electrolytes among a representative sample of U.S. adults ages 20–69 years. These data 
allow assessment of the associations of urinary sodium and potassium excretion with blood 
pressure in the U.S. population, unbiased by self-report of food intake. We hypothesized that 
higher excreted sodium and sodium-to-potassium ratio would be significantly associated 
with higher blood pressure and odds of hypertension, and that higher potassium excretion 
would be inversely associated with blood pressure and odds of hypertension.
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METHODS
Design
Cross-sectional survey data were analyzed from the 2014 NHANES, a nationally-
representative survey of noninstitutionalized persons in the U.S. For the purposes of 
reproducing the results, all SAS code is available to other researchers upon request to the 
corresponding author. All NHANES 24-hour urine study procedures are publicly available,
14, 15
 as are other NHANES 2013–2014 data and procedures.16 Access to the 24-hour urine 
data are limited to guarantee confidentiality of the survey participants. Secure, on-site access 
is granted through the National Center for Health Statistics (NCHS) Research Data Center.17 
NHANES was approved by the NCHS research ethics review board and participants gave 
informed consent.
In 2014 only, one-half of NHANES non-pregnant participants aged 20–69 years who were 
examined in the Mobile Examination Center (MEC) were randomly selected to participate in 
the 24-hour urine collection study (n=1,103). Methods for 24-hour urine collection are 
described in detail elsewhere.14, 15 In brief, collection kits were provided to participants and 
study staff explained procedures. Participants were randomly assigned to collect 24-hour 
urine samples on either a weekday or a weekend day, and when possible, participants both 
started and finished the 24-hour collection at the MEC. Of participants who collected a 
complete 24-hour urine specimen (n=827), some (n=585) were randomly selected to provide 
a second 24-hour urine collection 3–10 days later, to allow for estimation of day-to-day 
variation. Urine specimens were considered incomplete if: start and end time were not 
recorded and could not be ascertained; length of collection time was less than 22 hours; total 
urine volume was less than 400 ml; a female participant was menstruating; or a participant 
reported that more than a few drops of urine were missed during collection. NHANES did 
not analyze samples that were collected over less than 22 hours and the longest collection 
time analyzed was 27.1 hours. To account for collections that were shorter or longer than 24 
hours, NHANES provided adjusted 24-hour urine volume for each participant (total volume 
divided by collection time, multiplied by 24), which we used for calculation of estimated 24-
hour urinary sodium and potassium excretion. Urinary sodium and potassium were assessed 
using Beckman Synchron DxC800, which uses indirect ion selective electrode methodology 
to determine ion concentration. Of participants selected for the first 24-hour urine collection, 
827 (75% of 1,103) returned a complete specimen, and approximately half of those (n=436; 
75% of 585) returned a complete specimen for the second 24-hour urine collection. The 
unweighted response rate of the examined sample in NHANES 2013–2014 was 66% for 
adults 20–69 years. The overall component response rate for the first 24-hour urine 
collection was 50% (75% of 66%). An additional 61 participants were excluded due to 
missing information on variables included in this analysis (described below), leaving 766 
participants for analysis.
Main Outcomes and Measures
Up to three brachial systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
readings were averaged to determine mean blood pressure values. All participants completed 
at least two blood pressure measurements, and nearly all (>99%) completed three 
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measurements. Blood pressure readings were taken by trained technicians using a calibrated 
mercury sphygmomanometer with the cuff appropriate for a participant’s arm 
measurements, while participants were in a sitting position in the MEC after at least 5 
minutes of rest; detailed procedures and equipment are described elsewhere.18 Hypertension 
was defined as mean SBP ≥140 mm Hg, mean DBP ≥90 mm Hg, or self-reported use of 
antihypertensive medication. Among those who did not meet criteria for hypertension, 
prehypertension was defined as a mean SBP of 120–139 mm Hg or a mean DBP of 80–89 
mm Hg. Optimal blood pressure was defined as a mean SBP <120 mm Hg and mean DBP 
<80 mm Hg among participants not using antihypertensive medication. In addition to above 
categorical variables indicating hypertension status, associations with continuous measures 
were also examined for DBP, SBP, and mid blood pressure. Mid blood pressure (SBP + 
DBP, divided by two) was identified as the most informative measure for stroke mortality 
and ischemic heart disease mortality, compared with SBP, DBP, pulse pressure, and mean 
arterial pressure by the Prospective Studies Collaborative.19
Estimated usual mean 24-hour sodium and potassium excretion, as well as sodium to 
potassium ratio, were calculated using measurement error models that included a second 24-
hour excretion, collected among a sample of 436 participants with an initial 24-hour urine 
collection, to account for day-to-day variation.20 The National Cancer Institute measurement 
error method (and corresponding SAS macro) was used for estimating usual sodium and 
potassium excretion.21
Measurement error models and multivariable regression models included age, sex, race/
ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, non-Hispanic Asian, and 
other), body mass index (BMI), educational attainment (any higher education versus a high 
school degree, GED, or less), self-reported history of CVD (congestive heart failure, 
coronary heart disease, angina/angina pectoris, heart attack, or stroke), diabetes status (self-
reported diagnosis by a health care provider or use of a diabetes medication), chronic kidney 
disease (CKD; estimated glomerular filtration rate <60 mL/min/1.73 m2 or urinary albumin/
creatinine ratio > 30 mg/g),22 smoking status (current, former, or never smoker), and self-
reported physical activity (ideal: ≥ 75 minutes per week vigorous intensity or ≥150 minutes 
per week moderate or combination of moderate and vigorous activity; intermediate: 5–74 
minutes per week vigorous intensity or 10–149 minutes per week moderate or combination 
of moderate and vigorous activity; or inactive). Self-reported alcohol use was available for a 
subset of participants; higher than recommended alcohol use was defined as an average of 
more than two alcoholic drinks per day for men or more than one drink per day for women. 
One drink was defined for NHANES participants as 12 oz. beer, a 5 oz. glass of wine, or one 
and half ounces of liquor.
Statistical Analysis
Demographic and health characteristics were compared across hypertension status categories 
using t-tests and analysis of variance (ANOVA) for continuous variables and Rao-Scott F 
adjusted chi-square test for categorical variables. We compared least square means of usual 
sodium excretion, potassium excretion, and sodium-to-potassium ratio, adjusted for age, sex, 
race/ethnicity, and BMI, across hypertension status categories using ANOVA. Fully-adjusted 
Jackson et al. Page 4
Circulation. Author manuscript; available in PMC 2019 January 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
multivariable linear and logistic regression models additionally included education, history 
of CVD, diabetes, chronic kidney disease, smoking status, and physical activity. Models 
examining sodium excretion simultaneously controlled for potassium excretion, and vice 
versa. Associations between sodium, potassium, and their ratio with measures of blood 
pressure were tested for non-linearity using Wald chi-square tests, and restricted cubic spline 
plots were created to examine relationships visually.23 Multivariable linear regression was 
used to assess the associations of sodium excretion (per 1,000 mg/d), potassium excretion 
(per 1,000 mg/d), and sodium-to-potassium ratio (per 0.5 unit molar ratio) with blood 
pressure (continuous variables: SBP, DBP, and mid blood pressure).
We compared blood pressure across population quartiles of sodium and potassium excretion 
using an alternative approach due the variability in sodium and potassium excretion, and, 
consequently, potential misclassification of individuals at or near the quartile cutpoints. 
Given that sodium, potassium, and sodium-to-potassium ratio had approximately linear 
relationships to blood pressure, we calculated the 12.5th, 37.5th, 62.5th, and 87.5th 
percentiles from the distribution of estimated usual excretion. Using the parameters from the 
linear regression models, we then estimated the adjusted mean SBP of these percentiles, 
which can be interpreted as the mean blood pressure value at the middle of each population 
quartile for sodium, potassium, or sodium-to-potassium ratio (Figure 1). For hypertension, 
we used multivariable logistic regression to assess associations with odds of hypertension, 
comparing the adjusted odds at the mid-values of each excretion quartile, Q4 (the 87.5th 
percentile), Q3 (62.5th percentile), and Q2 (37.5th percentile) vs. the lowest quartile (Q1, the 
12.5th percentile) using a similar approach as the linear regression models. To determine 
whether trends were significant across quartiles, a Satterthwaite adjusted F-test was used.
Sensitivity analyses were conducted: i) including creatinine as a covariate (n=766); (ii) 
restricted to persons not taking anti-hypertensive medications (n=587); (iii) restricted to 
persons without CVD (n=718); (iv) restricted to persons with complete 24-hour urine 
collection based on creatinine excretion criteria (n=565);24 (v) using multiple imputation 
(SAS proc MI with 5 imputed datasets) to impute data for persons who were missing 
covariate data, i.e., SBP, DBP, Hypertension, diabetes status, CVD, BMI, CKD (n=827); and 
(vi) including alcohol consumption as a covariate (n=717). Multivariable regression models 
were tested for interaction between the independent variable (sodium, potassium, or sodium-
to-potassium ratio) and all other covariates. All analyses used SAS 9.3 and SAS-callable 
SUDAAN (SAS Institute Inc., Cary, NC) with one year 24-hour urine sample weights to 
account for non-response and the complex survey design of NHANES.
RESULTS
Over half of U.S. adults age 20–69 were classified as hypertensive (weighted prevalence 
28.2%, 95% confidence interval [CI] 21.6–34.8) or pre-hypertensive (23.1%, 19.5–26.6), 
combined. Adults with hypertension were older, and had higher BMI, than those with 
prehypertension or optimal blood pressure (both p<0.01 for trend, Table 1). An addition, a 
higher proportion of adults with hypertension had a history of CVD, diabetes, or chronic 
kidney disease (all p<0.01).
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Sodium, potassium, and sodium-to-potassium ratio did not differ by hypertension status after 
adjustment for age, sex, race/ethnicity, and BMI (Table 2). In fully-adjusted models 
additionally including education, history of CVD, diabetes, chronic kidney disease, smoking 
status, and physical activity (Figure 1), average SBP was higher across increasing quartiles 
of sodium excretion (p<0.01 and sodium-to-potassium ratio (p<0.01). Across higher 
quartiles of potassium excretion, SBP was lower (p<0.01). Associations between estimated 
usual excretion of sodium, potassium, and their ratio with systolic blood pressure were 
approximately linear (Figure 2), and tests for non-linearity were not significant.
In fully adjusted linear regression models (Table 3), sodium excretion (per 1000 mg/day 
higher) was directly associated with SBP (4.58 mmHg, 95% CI 2.64, 6.51), DBP (2.25 
mmHg, 95% CI 0.83, 3.67), and mid blood pressure (3.41 mmHg, 95% CI 1.97, 4.86). 
Potassium excretion (per 1000 mg/day higher) was inversely associated with SBP (−3.72 
mmHg, 95% CI −6.01, −1.42) and mid blood pressure (−1.98 mmHg, 95% CI −3.37, −0.59). 
Molar sodium-to-potassium ratio (per 0.5 unit higher) was directly associated with SBP 
(1.72 mmHg, 95% CI 0.76, 2.68) and mid blood pressure (1.01 mmHg, 95% CI 0.31, 1.71). 
In the fully adjusted multivariable logistic model (Table 4), persons in the highest (Q4, 
87.5th percentile) compared to lowest quartile of sodium excretion (Q1, 12.5th percentile) 
had 4 times greater odds of having hypertension (OR 4.22, 95% CI 1.36, 13.15).
Results remained robust in sensitivity analyses (eTable 1). Interactions between independent 
variables (sodium, potassium, or sodium-to-potassium ratio) and other model covariates 
were not statistically significant (data not shown) after correction for multiple comparisons. 
Although the interaction of sodium excretion with BMI was not significant, BMI-stratified 
models suggest the association of sodium and blood pressure was significant among obese 
but not overweight or healthy weight adults (see eTable 2).
DISCUSSION
This nationally representative cross-sectional study, using the first-ever collection of 24-hour 
urine in NHANES to estimate usual excretion, demonstrated a direct association between 
sodium excretion and multiple measures of blood pressure among US adults. Sodium-to-
potassium ratio was also directly associated with SBP, while potassium excretion was 
inversely associated with SBP. These results are consistent with prior findings of urinary 
electrolyte excretion and blood pressure in other studies.25–28
The magnitude of the association between SBP and 24-hour urinary sodium excretion in the 
present study (4.58 mmHg higher per 1000 mg/d difference in estimated usual excretion), 
was much greater than previously reported using 24-hour dietary intake data (1.04 mmHg 
higher per 1000mg/d difference in estimated usual intake) from NHANES 2005–2010.29 
Compared to self-reported dietary intake data, urinary sodium excretion does not depend on 
the accuracy of self-report or food composition tables, and 90–95% of ingested sodium is 
excreted through urine.2 In addition, dietary methods, which can be affected by self-report 
and nutrient coding errors, often fail to capture salt added in preparation (cooking) or at the 
table and some may not capture non-food sources of sodium such as supplements and 
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antacids, medications, or tap water.30 Such sources of measurement error in dietary studies 
may weaken the observed associations.
Similarly, the magnitude of the association between SBP and potassium excretion also 
appears larger in the present study (−3.72 mmHg lower per 1000mg/d difference in 
estimated usual excretion) compared to a prior investigation using dietary intake data from 
NHANES 2005–2010 (−1.24 mmHg lower per 1000mg/d difference in estimated usual 
intake).29 However, the present study found that sodium excretion was significantly 
associated with DBP but potassium excretion was not. This may be due to greater within-
individual variability in urinary potassium vs. sodium excretion as a measure of intake. 
Approximately 77–90% of potassium consumed is excreted in urine, compared to 90–95% 
of sodium,2 and the fraction of potassium excreted in urine varies between individuals and 
may be affected by race and medications.2, 31
Our findings are subject to the following limitations. First, the results are subject to potential 
selection bias, given that the response rate for the 24-hour urine collection was 50% (75% of 
66%). Although sample weights for the 24-hour urine collection were adjusted for non-
response, differences between respondents and non-respondents could reduce 
generalizability. Second, while 24-hour urinary excretion is considered the gold standard for 
estimated sodium intake, imperfect collection can under- or over-estimate excretion. For 
example, missed voids may result in under-estimates, or collection beyond 24-hour may 
result in over-estimates. To minimize this error, NHANES did not analyze samples that were 
collected for less than 22 hours and the longest collection time analyzed was 27.1 hours; 
adjusted 24-hour urine volume was used to estimate usual sodium and potassium excretion. 
In addition, we performed sensitivity analyses restricted to persons with complete 
collections based on creatinine criteria for completeness,24 and results remained robust. 
Third, due to the cross-sectional design of NHANES and lack of temporality, causality 
cannot be inferred from these data. Fourth, 24-hour urine was collected on only up to two 
days, 3–10 days apart, which could have diminished the observed associations with blood 
pressure due to random measurement error.13 Fifth, although a broad set of covariates were 
included in regression models, unmeasured confounding by additional factors could also 
play a role. Sixth, antihypertensive medications containing diuretics can impact sodium and 
potassium excretion, which could confound results. Among participants who reported taking 
antihypertensive medications, information was not available regarding medication type, so 
diuretic use could not be included specifically in multivariable models. However, results 
remained consistent in sensitivity analyses restricted to persons who reported not taking any 
antihypertensive medications. Finally, only 32 participants had estimated usual sodium 
excretion ≤2300 mg/day, so we were unable to examine this group separately to study the 
sodium and blood pressure relationship among persons meeting the 2015–2020 Dietary 
Guidelines for Americans recommendation of consuming <2300 mg sodium/day.
In conclusion, based on this cross-sectional analysis, we observed a linear, dose-response 
association between 24-hour sodium excretion and hypertension among US adults, and an 
inverse association between potassium excretion and hypertension. These associations were 
independent of numerous covariates in a large, diverse sample of adults. These cross-
sectional findings using gold-standard assessment methods, when added to the evidence base 
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from longitudinal and interventional studies, support dietary advice to lower sodium intake 
and increase consumption of potassium-containing foods as part of a healthy dietary pattern 
as recommended in the 2015–2020 Dietary Guidelines for Americans. A dietary pattern high 
in potassium, such as the Dietary Approaches to Stop Hypertension (DASH) diet which 
focuses on vegetables, fruits, whole grains, low fat dairy and lean protein, in combination 
with a low-sodium diet, had greater blood pressure lowering effects than either dietary 
approach alone.32 Advice from doctors and other health care professionals about sodium 
reduction is associated with action to reduce sodium intake.33 The health impact of 
individual and population-level strategies to increase potassium intake merits further 
research. Recommended public health strategies for sodium reduction focus on reducing the 
primary source of sodium in the US diet, salt added to commercially processed and prepared 
foods.34–36 Continued monitoring of the related health impact of such strategies is essential 
given that even small reductions in population sodium intake are projected to prevent 
thousands of deaths due to heart disease and stroke and save billions of dollars in health care 
costs annually.37
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Clinical Perspective
What is new?
• This study reports associations between usual sodium, potassium, and blood 
pressure using gold-standard 24-hour urinary data, collected for the first time 
among a nationally representative sample of adults in the United States.
• There is a strong, direct relationship between higher sodium excretion and 
higher blood pressure and hypertension.
• In addition, there was an inverse relationship between potassium excretion 
and blood pressure and hypertension.
What are the clinical implications?
• Hypertension is a key modifiable risk factor for cardiovascular disease, the 
leading cause of morbidity and mortality in the US.
• When added to the evidence base from longitudinal and interventional 
studies, these results support clinicians’ dietary advice to lower sodium intake 
and increase consumption of potassium-containing foods.
• The findings also support recommendations by clinicians to reduce sodium in 
combination with consuming a dietary pattern that is high in potassium, such 
as the Dietary Approaches to Stop Hypertension (DASH) diet, to help achieve 
a greater blood pressure lowering effect.
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Figure 1. Adjusted systolic blood pressure by mid-value of quartile of usual sodium excretion, 
usual potassium excretion, and their ratio, among adults aged 20–69, NHANES 2014
This figure presents adjusted mean systolic blood pressure at the 12.5th, 37.5th, 62.5th, and 
87.5th percentiles (mid-values of Q1, Q2, Q3, Q4) of usual sodium excretion (Panel A), 
usual potassium excretion (Panel B), and sodium-to-potassium ratio (Panel C), using average 
values for covariates. P-values indicate t-tests for trend from the survey-adjusted regression 
models.
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Figure 2. Cubic spline plots of the association between systolic blood pressure and usual sodium 
excretion, usual potassium excretion, and their ratio, among adults aged 20–69, NHANES 2014
In Panel A, the y-axis shows difference in systolic blood pressure across sodium excretion 
values compared to a reference value of 2.58g (the midpoint of the lowest quartile). The 
overall association was significant (p<0.001) and the test of non-linear association was not 
significant (p=0.41). Panel B shows difference in systolic blood pressure across potassium 
excretion values compared to a reference value of 1.48g. The overall association was 
significant (p=0.007) and the test of non-linear association was not significant (p=0.13). 
Panel C shows difference in systolic blood pressure across sodium-to-potassium ratio values 
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compared to a reference value of 2.27. The overall association was significant (p=0.006) and 
the test of non-linear association was not significant (p=0.28).
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Table 3
Association between sodium excretion, potassium excretion, and their ratio, with blood pressure among adults 
aged 20–69 years, NHANES 2014.
SBP DBP MidBP
β-coefficient (95% CI) β-coefficient (95% CI) β-coefficient (95% CI)
Sodium excretion
 Adjusted for age, sex, race/ethnicity 4.85* (2.88, 6.82) 2.08* (0.60,3.56) 3.47* (2.07, 4.86)
 Fully adjusted model 4.58* (2.64, 6.51) 2.25* (0.83, 3.67) 3.41* (1.97, 4.86)
Potassium excretion
 Adjusted for age, sex, race/ethnicity
−4.21* (−6.52, −1.91) −0.16 (−1.83,1.52) −2.19* (−3.55, −0.82)
 Fully adjusted model
−3.72* (−6.01, −1.42) −0.25 (−1.91, 1.42) −1.98* (−3.37, −0.59)
Sodium-to-potassium ratio
 Adjusted for age, sex, race/ethnicity 2.06* (1.06, 3.06) 0.43 (−0.41, 1.27) 1.24* (0.55, 1.94)
 Fully adjusted model 1.72* (0.76, 2.68) 0.30 (−0.53,1.12) 1.01* (0.31, 1.71)
*indicates p<0.01 for β-coefficient in the regression model.
β-coefficients for usual sodium and potassium indicate change in mmHg of blood pressure associated with 1000mg/d change in excretion; β-
coefficient for sodium-to-potassium ratio represents change in mmHg of blood pressure associated with 0.5 unit change in molar ratio.
Mid blood pressure = (SBP + DBP)/2
Fully adjusted models included age, sex, race/ethnicity plus BMI, education, history of CVD, diabetes status, chronic kidney disease, smoking 
status, and physical activity. In addition, models examining sodium excretion simultaneously adjusted for potassium excretion, and vice versa.
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Table 4
Association between hypertension and sodium excretion, potassium excretion, and their ratio, among adults 
aged 20–69 years, NHANES 2014.
Mid-value of Quartiles of Estimated Usual Excretion
Q1 (12.5th percentile)
OR, 95% CI
Q2 (37.5th percentile)
OR, 95% CI
Q3 (62.5th percentile)
OR, 95% CI
Q4 (87.5th percentile)
OR, 95% CI
Sodium excretion, mg/d* 2579 3249 3819 4772
 Adjusted for age, sex, race/ethnicity 1.0‡ 1.62 (1.21, 2.16) 2.51 (1.45, 4.34) 4.85 (1.89, 12.46)
 Fully adjusted model 1.0‡ 1.55 (1.10, 2.20) 2.26 (1.19, 4.29) 4.22 (1.36, 13.15)
Potassium excretion, mg/d* 1484 1896 2336 3043
 Adjusted for age, sex, race/ethnicity 1.0† 0.76 (0.60, 0.96) 0.56 (0.34, 0.92) 0.36 (0.15, 0.87)
 Fully adjusted model 1.0‡ 0.77 (0.62, 0.96) 0.59 (0.38, 0.93) 0.38 (0.17, 0.87)
Sodium-to-potassium molar ratio* 2.27 2.78 3.28 3.99
 Adjusted for age, sex, race/ethnicity 1.0† 1.33 (1.08, 1.65) 1.84 (1.17, 2.89) 2.69 (1.29, 5.61)
 Fully adjusted model 1.0 1.27 (0.97, 1.67) 1.61 (0.94, 2.77) 2.26 (0.90, 5.67)
*
These rows contain estimated mid-value of quartiles in the population.
†indicates p<0.05 and
‡indicates p<0.01 for trend across percentiles of estimated usual excretion based on Satterthwaite adjusted F-test.
Fully adjusted models included age, sex, race/ethnicity, education, BMI, history of CVD, diabetes status, chronic kidney disease, smoking status, 
and physical activity. In addition, models examining sodium excretion simultaneously adjusted for potassium excretion, and vice versa.
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